Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

19
Number of overlapping holdings
51.4%
% of BHCHX's 40 holdings also in FMED
33.9%
% of FMED's 61 holdings also in BHCHX
Overlap by Weight
Sector Drift (BHCHX minus FMED)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in BHCHX |
Weight in FMED |
Overlap | |
---|---|---|---|---|
BOSTON SCIENTIFIC CORPORATION | 5.3% | 6.6% | 5.3% | |
INTUITIVE SURGICAL, INC. | 5.8% | 4.6% | 4.6% | |
UNITEDHEALTH GROUP INCORPORATED | 7.3% | 4.1% | 4.1% | |
ARGENX SE ADR | 4.1% | 3.6% | 3.6% | |
STRYKER CORPORATION | 3.2% | 2.7% | 2.7% |
Position Highlights (Non-Overlapping Exposures)
BHCHX Overweight Relative to FMED
ELI LILLY AND COMPANY | 7.5% | |
ELI LILLY & CO | 7.5% | |
MERCK & CO., INC. | 4.8% | |
VERTEX PHARMACEUTICALS INC | 3.9% | |
VERTEX PHARMACEUTICALS INCORPORATED | 3.9% | |
ICON PLC | 3.2% | |
UNITEDHEALTH GROUP INC | 3.2% | |
UNITEDHEALTH GROUP INCORPORATED | 3.2% | |
THERMO FISHER SCIENTIFIC INC | 2.8% | |
MCKESSON CORPORATION | 2.7% |
BHCHX Underweight Relative to FMED
INSULET CORP | -4.5% | |
EXACT SCIENCES CORP | -3.2% | |
REGENERON PHARMACEUTICALS | -3.0% | |
UCB SA | -2.8% | |
PENUMBRA, INC. | -2.8% | |
ALNYLAM PHARMACEUTICALS INC | -2.7% | |
LIFESTANCE HEALTH GROUP, INC. | -2.6% | |
MASIMO CORPORATION | -2.2% | |
VEEVA SYSTEMS INC-CLASS A | -2.1% | |
DANAHER CORPORATION | -1.9% |